Philogen
Philogen S.p.A., a leading biopharmaceutical company headquartered in Italy, is renowned for its innovative approach in the field of drug development. Founded in 1996, Philogen has made significant strides in the industry, particularly in the areas of antibody-drug conjugates and targeted therapies. With a strong operational presence across Europe and the United States, the company focuses on creating unique therapeutic solutions for cancer and autoimmune diseases. Philogen's proprietary technologies, including its advanced platform for the discovery of novel antibodies, set it apart in a competitive market. Recognised for its commitment to scientific excellence, Philogen has achieved notable milestones, including successful clinical trials and strategic partnerships that enhance its market position. The company continues to push the boundaries of biopharmaceutical innovation, aiming to improve patient outcomes globally.
DitchCarbon Score
How does Philogen's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Philogen's score of 25 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Philogen's reported carbon emissions
In 2023, Philogen reported total carbon emissions of approximately 1,785,000 kg CO2e, comprising 575,000 kg CO2e from Scope 1 and about 1,210,000 kg CO2e from Scope 2 emissions. This marked an increase from 2022, where emissions were around 1,583,000 kg CO2e, with Scope 1 emissions at 454,000 kg CO2e and Scope 2 emissions at approximately 1,128,000 kg CO2e. In 2021, Philogen's emissions were significantly higher, totalling about 746,000 kg CO2e (Scope 1: 181,000 kg CO2e; Scope 2: 565,000 kg CO2e). The company has shown a trend of increasing emissions over the years, with 2020 emissions recorded at 318,000 kg CO2e (Scope 1: 138,000 kg CO2e; Scope 2: 180,000 kg CO2e). Despite the rising emissions, Philogen has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction strategies suggests a need for enhanced focus on sustainability practices within the organisation. As a company headquartered in Italy, Philogen operates in a global context where climate action is increasingly critical, and aligning with industry standards for emissions reduction could be beneficial for their long-term sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 138,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 162,000 | 000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Philogen is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
